A #Research paper recently #Published in Volume 18 of Aging, titled “Slowing intervertebral disc aging in mice through long-term systemic treatment with the senolytic BCL-2/BCL-xL proteolysis targeting chimera (PROTAC) 753b,” examines whether the senolytic PROTAC 753b can slow age-related intervertebral disc degeneration (IDD) in mice. Long-term systemic treatment with 753b reduced key features of disc degeneration in 22-month-old male mice, including matrix breakdown, loss of disc aggrecan, age-related structural changes, and inflammatory markers such as IL-6 and TNFα. These benefits, however, were not observed in female mice, highlighting potential sex-based differences in the role of cellular senescence in IDD and the response to senolytic therapies.
DOI - https://doi.org/10.18632/aging.206394
Corresponding author - Nam Viet Vo - nvv1@pitt.edu
Abstract video - https://www.youtube.com/watch?v=t0z4MULDr1A
Sign up for free Altmetric alerts about this article -
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206394
Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts
Podden och tillhörande omslagsbild på den här sidan tillhör
Aging Podcast. Innehållet i podden är skapat av Aging Podcast och inte av,
eller tillsammans med, Poddtoppen.